Kiniksa Pharmaceuticals International Plc (KNSA)
42.67
+0.94
(+2.25%)
USD |
NASDAQ |
Jan 09, 16:00
42.60
-0.07
(-0.16%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Liabilities (Quarterly): 176.95M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.346M |
| ADMA Biologics, Inc. | 137.50M |
| NovoCure Ltd. | 1.020B |
| LivaNova Plc | 1.400B |
| Akanda Corp. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 712.33M |
| Shareholders Equity (Quarterly) | 535.38M |
| Debt to Equity Ratio | 0.0182 |
| Current Ratio | 3.848 |
| Net Debt Paydown Yield | 0.01% |